Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade

Shares of Jazz Pharmaceuticals (JAZZ) have gained 10.8% over the past four weeks to close the last trading session at $111.60, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $174.83 indicates a potential upside of 56.7%. The average comprises 18 short-term price targets ranging from a low of $113 to a high of $230, with a standard deviation of $33.43. While the lowest estimate ...